Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- COPD therapy
Drug therapy – Update 2025
- Focus on prevention
Colorectal cancer screening – an update
- From symptom to diagnosis
Oncology – Thymoma
- Patient-centered rounds in medicine
Aligning care with the patient
- Shared decision making
Participatory decision-making using the example of diets for type 1 diabetes
- Migraine and vascular regulation
CGRP-targeted migraine therapies for vascular risk patients
- Chronic and acute coronary syndrome
Proactive and evidence-based decision-making
- Pediatric multiple sclerosis